EU, method C preference [Two-Stage / GS Designs]

posted by ElMaestro  – Denmark, 2019-10-11 12:25 (2436 d 17:19 ago) – Posting: # 20683
Views: 10,375

Hi all,

I remember having heard EU regulators mention preference for method C out of consideration for the type I error. But I can't seem to find a presentation from anyone saying so. Do you know, do one of you experts have a link or a presentation by a regulator where this was stated?

Many thanks.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
111 visitors (0 registered, 111 guests [including 26 identified bots]).
Forum time: 05:44 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5